Home ProductsPharmaceutical Raw Materials

Cas:1527-89-5 Pharmaceutical grade 3-methoxybenzontrile

Cas:1527-89-5 Pharmaceutical grade 3-methoxybenzontrile

    • Cas:1527-89-5 Pharmaceutical grade 3-methoxybenzontrile
    • Cas:1527-89-5 Pharmaceutical grade 3-methoxybenzontrile
    • Cas:1527-89-5 Pharmaceutical grade 3-methoxybenzontrile
  • Cas:1527-89-5 Pharmaceutical grade 3-methoxybenzontrile

    Product Details:

    Place of Origin: China
    Brand Name: BeiLi
    Certification: ISO 9001:2008
    Model Number: MBN.99P.N

    Payment & Shipping Terms:

    Minimum Order Quantity: unlimited
    Price: negotiation
    Packaging Details: plastic drum/carton drum/bag/
    Delivery Time: 3-10 working days
    Payment Terms: negotiation
    Contact Now
    Detailed Product Description
    Synonym: M-Anisonitrile; AKOS B004087; 3-ANISONITRILE; 3-METHOXYBENZONITRILE; 3-CYANOANISOLE; M-METHOXYBENZONITRILE; Benzonitrile, 3-methoxy-; Benzonitrile, M-methoxy- Molar Mass (g/mol): 133.15
    Reach PR#: 05-2119085533-37-0000 Grade: Pharmaceutical Grade
    Density: 1.089 G/mL At 25 °C P/N#: MBN.99P.N
    Purity: ≥99.0%

     

    Cas:1527-89-5 Pharmaceutical grade 3-methoxybenzontrile

     

     

    3-Methoxybenzonitrile, also known as 3-methoxy benzonitrile, m-methoxy benzonitrile, colorless or slightly yellow liquid.

     

    CAS No: 1527-89-5

    EC No: 216-201-3

    Packaging:200kgs/iron drum with plastic lining

     

     

    1. Basic Information

     

    Name 3-methoxybenzontrile
    Synonym m-Anisonitrile; AKOS B004087; 3-ANISONITRILE; 3-METHOXYBENZONITRILE; 3-CYANOANISOLE; M-METHOXYBENZONITRILE; Benzonitrile, 3-methoxy-; Benzonitrile, m-methoxy-
    Molecular formula C8H7NO
    Molar mass
    (g/mol)
    133.15
    Reach
    PR#
    05-2119085533-37-0000
    Density 1.089 g/mL at 25 °C
    Melting point  
    Boling point 111.0~112.0ºC(13mmHg)
    Solubility  

     

     

    2. Specifications

     

    P/N# MBN.99P.N Grade Pharmaceutical grade
    Purity ≥99.0% Melting range  
    Water   Quality standard meets company specification

     

     

    3. Application

     

    Used as a pharmaceutical intermediate, it is an important intermediate of the new antipyretic analgesic - tapentadol. The drug is mainly used to relieve moderate and severe acute pain, especially for the relief of adults over 18 years of age. Its quick release tablets were approved by the US Food and Drug Administration (trade name: NUCNTA) in November 2008 to relieve moderate and severe acute pain;Its sustained-release tablets were approved for marketing in August 2012 (trade name: NUCYNTA ER) for the treatment of adult diabetic neuropathy (DPN) -related neuropathic pain.In addition, it also can participate in a variety of organic synthesis.

     

     

    4. Storage condition

     

    Store in a cool, dry place, avoid direct sunlight. Store in a tightly closed container.

     

     

    5. Hazards Identification

     

    EMERGENCY OVERVIEW:Harmful by inhalation, in contact with skin and if swallowed.

    Potential Health Effects:The toxicological properties of this material have not been investigated. Use appropriate procedures to prevent opportunities for direct contact with the skin or eyes and to prevent inhalation.

     

     

    6. First Aid Measures

     

    Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids.

     

    Skin: Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.

     

    Ingestion: Do not induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.

     

    Inhalation: Remove from exposure and move to fresh air immediately.

     

     

     

     

    Contact Details
    BeiLi Chemicals (Zhangjiagang) Co., Ltd.

    Contact Person: lick

    Send your inquiry directly to us (0 / 3000)

    Other Products